Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 4 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CNY
The 7 analysts offering 12 month price targets for Keymed Biosciences Inc have a median target of 58.74, with a high estimate of 71.99 and a low estimate of 49.99. The median estimate represents a 31.41% increase from the last price of 44.70.
High | 61.0% | 71.99 |
Med | 31.4% | 58.74 |
Low | 11.8% | 49.99 |
Earnings history & estimates in CNY
Average growth rate | +39.51% |
More ▼
Revenue history & estimates in CNY
Average growth rate | +122.31% |
More ▼